Ledger.Open graph →
SEC Form D · filed September 14, 2018

Vedantra Pharmaceuticals, Inc

Offering
$36.2M
Sold
$25.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Vincent G. Pollesel · Garson, Ontario, CanadaDirectorD. J. Durivage · Dublin, OHDirectorMatthew J. Aiello · Crownsville, MDExec · DirectorMatt F. Lopez · Ladera Ranch, CADirectorGary R. Peterson · Houston, TXDirectorMichael E. Edleson · Grand Cayman, Cayman IslandsDirectorMatt Belcher · San Diego, CADirectorStephanie Sy · San Diego, CAExec · DirectorMaren Steinberg · DENVER, CODirectorStephen H. Mann · NORTH VANCOUVER, British Columbia, CanadaDirectorRichard H. Meli · NORTH VANCOUVER, British Columbia, CanadaDirectorTony H. Young · NORTH VANCOUVER, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗